Literature DB >> 10796842

Antistreptococcal interventions for guttate and chronic plaque psoriasis.

C M Owen1, R J Chalmers, T O'Sullivan, C E Griffiths.   

Abstract

BACKGROUND: Guttate psoriasis is a distinctive acute form of psoriasis which characteristically occurs in children and young adults. It is closely associated with preceding streptococcal sore throat or tonsillitis. Some authorities have claimed that ordinary (chronic plaque) psoriasis may also be made worse by infection at distant sites. Although many dermatologists have recommended using antibiotics for guttate psoriasis in particular, it is not clear whether they influence the course of either form of psoriasis. Some dermatologists have also recommended tonsillectomy for psoriasis in patients with recurrent streptococcal sore throat.
OBJECTIVES: To assess the evidence for effectiveness of antistreptococcal interventions including antibiotics and tonsillectomy in the management of acute guttate and chronic plaque psoriasis. SEARCH STRATEGY: We searched the Cochrane Clinical Trials Register (Cochrane Library, Issue 3, 1999), Medline (1966- September 1999), Embase (1988-September 1999), the Salford Database of Psoriasis Trials (to November 1999) and the European Dermato-Epidemiology Network (EDEN) Psoriasis Trials Database (to November 1999) for terms [STREPTOCOCC* or ANTIBIOTIC* or TONSIL*] and PSORIASIS using the Cochrane Skin Group search strategy. SELECTION CRITERIA: Randomised trials of one or more antistreptococcal interventions in patients with guttate or chronic plaque psoriasis. DATA COLLECTION AND ANALYSIS: Two reviewers independently examined each retrieved trial for eligibility and quality. MAIN
RESULTS: The one eligible trial we identified compared the use of two oral antibiotic schedules in 20 psoriasis patients, predominantly of guttate type, who had evidence of beta-haemolytic streptococcal colonisation. Either rifampicin or placebo was added to the end of a standard course of antistreptococcal antibiotic (phenoxymethylpenicillin or erythromycin). No patient in either arm of the study improved during the observation period. No randomised trials of tonsillectomy for psoriasis were identified. REVIEWER'S
CONCLUSIONS: Although it is well known that guttate psoriasis may be precipitated by streptococcal infection, there is no firm evidence to support the use of antibiotics either in the management of established guttate psoriasis or in preventing the development of guttate psoriasis following streptococcal sore throat. Although both antibiotics and tonsillectomy have frequently been advocated for patients with recurrent guttate psoriasis or chronic plaque psoriasis, there is to date no good evidence that either intervention is beneficial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10796842     DOI: 10.1002/14651858.CD001976

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  14 in total

Review 1.  Psoriasis and its management.

Authors:  Catherine H Smith; J N W N Barker
Journal:  BMJ       Date:  2006-08-19

Review 2.  Skin microbiome: genomics-based insights into the diversity and role of skin microbes.

Authors:  Heidi H Kong
Journal:  Trends Mol Med       Date:  2011-03-04       Impact factor: 11.951

3.  The role of tonsillectomy in psoriasis treatment.

Authors:  João Filipe Simões; João Ribeiro; Bárbara Roque Ferreira; Sofia Paiva
Journal:  BMJ Case Rep       Date:  2015-01-30

4.  Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis.

Authors:  Annabel Maruani; Mahtab Samimi; Natasha Stembridge; Rania Abdel Hay; Elsa Tavernier; Carolyn Hughes; Laurence Le Cleach
Journal:  Cochrane Database Syst Rev       Date:  2019-04-08

Review 5.  Indications for tonsillectomy stratified by the level of evidence.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

Review 6.  [The role of streptococci in psoriasis].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

7.  Lifestyle changes for treating psoriasis.

Authors:  Shu-Hua Ko; Ching-Chi Chi; Mei-Ling Yeh; Shu-Hui Wang; Yu-Shiun Tsai; Mei-Ya Hsu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

8.  Ustekinumab in the therapy of chronic plaque psoriasis.

Authors:  Jenna L O'Neill; Robert E Kalb
Journal:  Biologics       Date:  2009-07-13

9.  Strengths and limitations of evidence-based dermatology.

Authors:  Hywel C Williams
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

10.  The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology.

Authors:  Anand Reddi; Laura Prescott; Elizabeth Doney; Finola Delamere; Ramya Kollipara; Robert P Dellavalle; Hywel C Williams
Journal:  J Evid Based Med       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.